{Ifinatamab, | This promising therapeutic compound , | The developing therapeutic, is receiving considerable interest owing to its targeted approach of function . It selectively targets the B7-H3 molecule, , the membrane molecule often present on a range of tumor cells . Preliminary clinical results suggest promising activity for treating a selecti